journal article·2024-02-09Open access

The Antibacterial Properties of a Silver Multilayer Coating for the Prevention of Bacterial Biofilm Formation on Orthopedic Implants—An In Vitro Study

Sanne W. G. van Hoogstraten, Janine Fechter, Rainer Bargon, Julia L. van Agtmaal, Laura C. W. Peeters, Jan Geurts, Jacobus J. C. Arts

Coatings· Volume 14· Issue 2

Abstract

The prevention of biofilm formation on orthopedic implants is essential, as biofilms are the main challenge in the effective treatment of periprosthetic joint infection (PJI). A silver multilayer (SML) coating was developed to prevent biofilm formation on the implant surface. Previous studies have already demonstrated its antibacterial properties without cytotoxic effects. However, the coating has not been previously tested when applied to common titanium surfaces used in total joint arthroplasty implants. These surfaces often have increased roughness and porosity in the case of cementless implants, which can alter the antibacterial effect of the coating. In this study, we assessed the antibacterial and anti-biofilm properties of the SML coating on corundum-blasted and plasma-sprayed microporous-coated titanium alloy surfaces, using S. aureus, S. epidermidis, and E. coli. An antibacterial activity test following the principles of ISO 22196, ASTM E2180-18, and JIS Z 2801 standards was performed, as well as a biofilm proliferation assay investigating bacterial adhesion and biofilm formation. The SML coating exhibited strong antibacterial effects for all bacterial strains. After 24 h biofilm culture, a >4-log reduction in CFU was induced by the SML coating for S. epidermidis and E. coli on the corundum-blasted and plasma-sprayed microporous-coated titanium surfaces, respectively, when compared to the uncoated surfaces. The coating showed bactericidal properties against Gram-positive bacteria on the corundum-blasted discs. The SML coating on two common titanium surfaces demonstrates significant potential as an effective strategy in combating PJI across a wide range of orthopedic implants.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory for Experimental Orthopaedics, Department of Orthopaedic Surgery, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre, 6229 Maastricht, The Netherlands

Department of Research and Development, Aesculap AG, Am Aesculap-Platz, 78532 Tuttlingen, Germany

Department of Biomedical Engineering, Orthopaedic Biomechanics, Eindhoven University of Technology, 5612 Eindhoven, The Netherlands

Funding

Health-Holland · Dutch Research Council (NWO)

References (71)

Show source-provided references
1. Mortality During Total Hip Periprosthetic Joint Infection10.1016/j.arth.2018.12.024 ↗
2. Epidemiology and new developments in the diagnosis of prosthetic joint infection10.5301/ijao.5000168 ↗
3. Prosthetic Joint Infections: Bane of Orthopedists, Challenge for Infectious Disease Specialists
4. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population10.1016/j.arth.2009.04.027 ↗
5. Incidence of periprosthetic joint infection after primary total hip arthroplasty is underestimated: A synthesis of meta-analysis and bibliometric analysis10.1186/s13018-023-04060-5 ↗
6. Disease burden of prosthetic joint infections after hip and knee joint replacement in Finland during 1999-2004: Capture-recapture estimation10.1016/j.jhin.2009.10.029 ↗
7. Prosthetic joint infection risk after TKA in the Medicare population10.1007/s11999-009-1013-5 ↗
8. Day, C.W., Costi, K., Pannach, S., Atkins, G.J., Hofstaetter, J.G., Callary, S.A., Nelson, R., Howie, D.W., and Solomon, L.B. (2021). Long-Term Outcomes of Staged Revision Surgery for Chronic Periprosthetic Joint Infection of Total Hip Arthroplasty. J. Clin. Med., 11.10.3390/jcm11010122 ↗
9. Epidemiology of total hip arthroplasty: Demographics, comorbidities and outcomes10.1186/s42836-022-00156-1 ↗
10. Epidemiology of primary and revision total knee arthroplasty: Analysis of demographics, comorbidities and outcomes from the national inpatient sample10.1186/s42836-023-00175-6 ↗
11. The Epidemiology of Revision Total Knee Arthroplasty in the United States10.1007/s11999-009-0945-0 ↗
12. Projected Volume of Primary Total Joint Arthroplasty in the U.S., 2014 to 203010.2106/JBJS.17.01617 ↗
13. Periprosthetic joint infection: Current concepts and outlook10.1302/2058-5241.4.180092 ↗
14. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 203010.2106/00004623-200704000-00012 ↗
16. The Antibiotic Resistance Crisis
17. Antimicrobial treatment of patients with a periprosthetic joint infection: Basic principles10.1186/s42836-023-00169-4 ↗
18. Baddour, L.M., and Chen, A.F. (2023). Prosthetic Joint Infection: Treatment, UpToDate.
19. Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention?10.5312/wjo.v5.i3.218 ↗
20. Projected Economic Burden of Periprosthetic Joint Infection of the Hip and Knee in the United States10.1016/j.arth.2020.12.005 ↗
21. Outcome of Debridement, Antibiotics, and Implant Retention for Staphylococcal Hip and Knee Prosthetic Joint Infections, Focused on Rifampicin Use: A Systematic Review and Meta-Analysis10.1093/ofid/ofab298 ↗
22. The role of microbial biofilms in prosthetic joint infections10.3109/17453674.2014.966290 ↗
24. Arts, J., and Geurts, J. (2017). Management of Periprosthetic Joint Infections (PJIs), Springer.
25. Bacterial biofilms: Development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era10.1101/cshperspect.a010306 ↗
26. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention10.1093/cid/cis746 ↗
27. Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study10.1016/j.jinf.2022.07.009 ↗
28. Increased Incidence of Methicillin-Resistant Staphylococcus aureus in Knee and Hip Prosthetic Joint Infection10.1016/j.arth.2023.02.025 ↗
29. Biofilm properties in relation to treatment outcome in patients with first-time periprosthetic hip or knee joint infection
30. Li, H., Wang, D., Zhang, W., Xu, G., Xu, C., Liu, W., and Li, J. (2023). Potential side effects of antibacterial coatings in orthopaedic implants: A systematic review of clinical studies. Front. Bioeng. Biotechnol., 11.10.3389/fbioe.2023.1111386 ↗
31. The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry10.2147/IJN.S246764 ↗
32. Antimicrobial coated implants in trauma and orthopaedics—A clinical review and risk-bene fi t analysis10.1016/j.injury.2016.12.011 ↗
33. Effect of various concentrations of antibiotics on osteogenic cell viability and activity10.1002/jor.21343 ↗
34. Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts10.1016/j.actbio.2013.09.037 ↗
35. Antimicrobial coatings for orthopaedic implants—Ready for use?10.7150/jbji.46508 ↗
36. A Comparison of Bacterial Adhesion and Biofilm Formation on Commonly Used Orthopaedic Metal Implant Materials: An In vitro Study10.4103/ortho.IJOrtho_66_18 ↗
37. Fabritius, M., Al-Munajjed, A.A., Freytag, C., Jülke, H., Zehe, M., Lemarchand, T., Arts, J.J., Schumann, D., Alt, V., and Sternberg, K. (2020). Antimicrobial silver multilayer coating for prevention of bacterial colonization of orthopedic implants. Materials, 13.10.3390/ma13061415 ↗
38. Ag/SiOxCy plasma polymer coating for antimicrobial protection of fracture fixation devices10.1002/jbm.b.31641 ↗
39. Evaluation of a silver-impregnated coating to inhibit colonization of orthopaedic implants by biofilm forming methicillin-resistant Staphylococcus pseudintermedius10.3415/VCOT-15-08-0134 ↗
40. Osseointegration of titanium implants with a novel silver coating under dynamic loading10.22203/eCM.v039a16 ↗
41. Treatment of a Recurrent Periprosthetic Joint Infection with an Intramedullary Knee Arthrodesis System with Low-Amount Metallic Silver Coating10.7150/jbji.34484 ↗
42. Zheng, S., Bawazir, M., Dhall, A., Kim, H.-e., He, L., Heo, J., and Hwang, G. (2021). Implication of Surface Properties, Bacterial Motility, and Hydrodynamic Conditions on Bacterial Surface Sensing and Their Initial Adhesion. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.643722 ↗
43. (2011). Measurement of Antibacterial Activity on Plastics and Other Non-Porous Surfaces (Standard No. ISO 22196:2011(E)).
44. (2018). Standard Test Method for Determining the Activity of Incorporated Antimicrobial Agent(s) in Polymeric or Hydrophobic Materials (Standard No. ASTM E2180-18).
45. In vitro methods for the evaluation of antimicrobial surface designs10.1016/j.actbio.2018.02.001 ↗
46. A rabbit model of implant-related osteomyelitis inoculated with biofilm after open femoral fracture
47. Following the mechanisms of bacteriostatic versus bactericidal action using Raman spectroscopy10.3390/molecules181113188 ↗
48. Quantification of biofilm biomass by staining: Non-toxic safranin can replace the popular crystal violet10.1016/j.mimet.2017.08.003 ↗
49. Quantitative Comparison of the Antimicrobial Efficiency of Leaching versus Nonleaching Polymer Materials10.1002/mabi.201500266 ↗
50. A new method for screening anti-infective biomaterials10.1038/79568 ↗
51. Effect of Silver Ions on Transport and Retention of Phosphate by Escherichia coli10.1128/jb.152.1.7-13.1982 ↗
52. The molecular mechanisms of copper and silver ion disinfection of bacteria and viruses10.1080/10643388909388351 ↗
53. Dakal, T.C., Kumar, A., Majumdar, R.S., and Yadav, V. (2016). Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles. Front. Microbiol., 7.10.3389/fmicb.2016.01831 ↗
54. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli10.1128/AEM.02001-07 ↗
55. Wiegand, C., Völpel, A., Ewald, A., Remesch, M., Kuever, J., Bauer, J., Griesheim, S., Hauser, C., Thielmann, J., and Tonndorf-Martini, S. (2018). Critical physiological factors influencing the outcome of antimicrobial testing according to ISO 22196/JIS Z 2801. PLoS ONE, 13.10.1371/journal.pone.0194339 ↗
56. Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of GramPositive Bacterial Infections10.1086/381972 ↗
57. Microbial biofilm growth vs. tissue integration: “the race for the surface” experimentally studied10.1016/j.actbio.2008.12.011 ↗
58. A systematic review of animal models for Staphylococcus aureus osteomyelitis10.22203/eCM.v027a15 ↗
59. Influence of material and microtopography on the development of local infection in vivo: Experimental investigation in rabbits10.1177/039139880903200916 ↗
60. In vivo evaluation of the effect of intramedullary nail microtopography on the development of local infection in rabbits10.1177/039139881003300913 ↗
61. The virulence of staphylococcus pyogenes for man. A study of the problems of wound infection
62. Sonication of Removed Hip and Knee Prostheses for Diagnosis of Infection10.1056/NEJMoa061588 ↗
63. Standar, K., Kreikemeyer, B., Redanz, S., Munter, W.L., Laue, M., and Podbielski, A. (2010). Setup of an in vitro test system for basic studies on biofilm behavior of mixed-species cultures with dental and periodontal pathogens. PLoS ONE, 5.10.1371/journal.pone.0013135 ↗
64. Is biofilm removal properly assessed? Comparison of different quantification methods in a 96-well plate system10.1007/s00253-016-7396-9 ↗
65. The influence of surface chemistry on the kinetics and thermodynamics of bacterial adhesion10.1038/s41598-018-35343-1 ↗
66. Dassanayake, R.P., Falkenberg, S.M., Stasko, J.A., Shircliff, A.L., Lippolis, J.D., and Briggs, R.E. (2020). Identification of a reliable fixative solution to preserve the complex architecture of bacterial biofilms for scanning electron microscopy evaluation. PLoS ONE, 15.10.1371/journal.pone.0233973 ↗
67. Cunliffe, A.J., Askew, P.D., Stephan, I., Iredale, G., Cosemans, P., Simmons, L.M., Verran, J., and Redfern, J. (2021). How do we determine the efficacy of an antibacterial surface? A review of standardised antibacterial material testing methods. Antibiotics, 10.10.3390/antibiotics10091069 ↗
68. Prosthetic joint infection caused by gram-negative organisms10.1016/j.arth.2011.03.044 ↗
69. Perni, S., Bojan, B., and Prokopovich, P. (2023). A retrospective study of risk factors, causative micro-organisms and healthcare resources consumption associated with prosthetic joint infections (PJI) using the Clinical Practice Research Datalink (CPRD) Aurum database. PLoS ONE, 18.10.1371/journal.pone.0282709 ↗
70. Robertson, J., McGoverin, C., Vanholsbeeck, F., and Swift, S. (2019). Optimisation of the Protocol for the LIVE/DEAD((R)) BacLight(TM) Bacterial Viability Kit for Rapid Determination of Bacterial Load. Front. Microbiol., 10.10.3389/fmicb.2019.00801 ↗
71. Quantitative and Qualitative Assessment Methods for Biofilm Growth: A Mini-review